Differences among young adults, adults and elderly chronic myeloid leukemia patients

Fabio Castagnetti, Gabriele Gugliotta, Michele Baccarani, +151

Annals of Oncology

Hematological MalignancyFamily MedicineYoung AdultsAgingHealth Policy +6

Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans Syndrome

Maurizio Musso, Ferdinando Porretto, Alessandra Crescimanno, +4

Lupus

Cell TherapyImmunologyAllogeneic Stem CellRefractory Evans SyndromeStem Cell Transplantation +17

Palonosetron (Aloxi®) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy

Maurizio Musso, Renato Scalone, Vincenza Bonanno, +5

Supportive Care in Cancer

OncologyMedicineMetronomic TherapyClinical PharmacologyPharmacotherapy +5

Structure−Activity Relationship Studies of Novel Heteroretinoids:  Induction of Apoptosis in the HL-60 Cell Line by a Novel Isoxazole-Containing Heteroretinoid

Daniele Simoni, Francesco Paolo Invidiata, Riccardo Rondanin, +6

Journal of Medicinal Chemistry

Chemoprevention StrategyRetinoic Acid ReceptorApoptosisCell DeathCis-isomer 14B +18

Crohn’s disease complicated by relapsed extranodal Hodgkin’s lymphoma: prolonged complete remission after unmanipulated PBPC autotransplant

Maurizio Musso, Ferdinando Porretto, Alessandra Crescimanno, +3

Bone Marrow Transplantation

Unmanipulated Pbpc AutotransplantAutoimmune DiseaseCrohn ’MedicineImmunology +6

Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease

Maurizio Musso, Ferdinando Porretto, Alessandra Crescimanno, +3

American Journal of Hematology

Cell TherapySevere Autoimmune DiseaseImmunologyImmunotherapyIntense Immunosuppressive Therapy +22

Granulocyte integrins before and after activation in acute ischaemic stroke

Gregorio Caimi, Baldassare Canino, Filippo Ferrara, +6

Journal of the Neurological Sciences

ThrombosisIschemic StrokeMedicineStroke-related ConditionCerebrovascular Disease +11

Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib

Stefania Stella, Valentina Zammit, Silvia Rita Vitale, +21

International Journal of Molecular Sciences

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study

Gabriele Gugliotta, Fausto Castagnetti, Massimo Breccia, +23

Haematologica

Excellent Outcomes at 3 Years with Nilotinib 800 Mg Daily In Early Chronic Phase, Ph+ Chronic Myeloid Leukemia (CML): Results of a Phase 2 GIMEMA CML WP Clinical Trial

Gianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, +22

Blood